Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 41Terminated 11Recruiting 4Active not recruiting 3Withdrawn 2Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Periampullary Tumors 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Octreotide × Clear all
NCT06085976 2023-10-17

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Clinica Universidad de Navarra, Universidad de Navarra

Phase 2 Unknown
62 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02920567 2016-09-30

Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion

Saint Vincent's Hospital, Korea

Phase NA Unknown
282 enrolled

Periampullary Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡